<h1 class="entry-title">Archives: Testimonials</h1>

12-year veteran in various positions including Director of Quality

“…The systems you delivered are highly customized to meet our compliance requirements and business needs.  All interactions were very professional and goal-oriented. [We] did not have the ‘band-width’ in a couple areas which ComplianceAcuity helped us cover:  1. Compliance and regulatory understanding, was/is not wide-spread.  2.  Having the skill sets and time to create Policies/Procedures/Work […]

CEO – Class II device Manufacturer

“…The biggest value ComplianceAcuity brought to the table for us was communication.  Not only did ComplianceAcuity interface directly with FDA on our behalf, but more importantly ComplianceAcuity got everyone in our organization on the same page and moving in the same direction. ComplianceAcuity continuously showed their tact and experience in interfacing with our personnel, breaking […]

Customer Service Supervisor – Class II & III device Manufacturer

“…Very patient and understanding – related well between different stakeholders and individual departmental issues – an absolute pleasure to deal with – extremely supportive of our objectives.  Extremely capable when navigating through the labyrinth of [company] business practices and providing concise solutions.  Assisted tremendously in encapsulating the core issues that needed to be resolved so […]

CEO – Class II device Manufacturer

“…Like many companies, we know “our business” but the intricacies of developing, implementing, and maintaining an effective medical device quality system was beyond our expertise (as illustrated by our recent inspection) and it was too late to gain traction on the project alone.  Kevin and his Associates at ComplianceAcuity from day one had a unique […]

Quality Manager, Class II devices

“…Definitely added value. With the gap audit, ComplianceAcuity found many crucial gaps and helped provide high level solutions to fill the gaps. Without the expertise of ComplianceAcuity our last FDA audit would have been a disaster…”